The Valley Desk

NCT03478787 · Interventional trial

Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque Psoriasis

Overall registry status Completed

Phase 3

Conditions Psoriasis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov